239 related articles for article (PubMed ID: 24906821)
21. Mesenchymal stem cells recruited by castration-induced inflammation activation accelerate prostate cancer hormone resistance via chemokine ligand 5 secretion.
Yu Y; Zhang Q; Ma C; Yang X; Lin R; Zhang H; Liu Y; Han Z; Cheng J
Stem Cell Res Ther; 2018 Sep; 9(1):242. PubMed ID: 30257726
[TBL] [Abstract][Full Text] [Related]
22. GLUT1 protects prostate cancer cells from glucose deprivation-induced oxidative stress.
Gonzalez-Menendez P; Hevia D; Alonso-Arias R; Alvarez-Artime A; Rodriguez-Garcia A; Kinet S; Gonzalez-Pola I; Taylor N; Mayo JC; Sainz RM
Redox Biol; 2018 Jul; 17():112-127. PubMed ID: 29684818
[TBL] [Abstract][Full Text] [Related]
23. Elevated level of inhibin-alpha subunit is pro-tumourigenic and pro-metastatic and associated with extracapsular spread in advanced prostate cancer.
Balanathan P; Williams ED; Wang H; Pedersen JS; Horvath LG; Achen MG; Stacker SA; Risbridger GP
Br J Cancer; 2009 Jun; 100(11):1784-93. PubMed ID: 19436293
[TBL] [Abstract][Full Text] [Related]
24. Expression of fucosyltransferase 8 is associated with an unfavorable clinical outcome in non-small cell lung cancers.
Honma R; Kinoshita I; Miyoshi E; Tomaru U; Matsuno Y; Shimizu Y; Takeuchi S; Kobayashi Y; Kaga K; Taniguchi N; Dosaka-Akita H
Oncology; 2015; 88(5):298-308. PubMed ID: 25572677
[TBL] [Abstract][Full Text] [Related]
25. Revisiting the substrate specificity of mammalian α1,6-fucosyltransferase reveals that it catalyzes core fucosylation of
Yang Q; Zhang R; Cai H; Wang LX
J Biol Chem; 2017 Sep; 292(36):14796-14803. PubMed ID: 28729420
[TBL] [Abstract][Full Text] [Related]
26. The expression profile and heterogeneity analysis of ERG in 633 consecutive prostate cancers from a single center.
Nie L; Pan X; Zhang M; Yin X; Gong J; Chen X; Xu M; Zhou Q; Chen N
Prostate; 2019 Jun; 79(8):819-825. PubMed ID: 30900303
[TBL] [Abstract][Full Text] [Related]
27. Sulfiredoxin as a Potential Therapeutic Target for Advanced and Metastatic Prostate Cancer.
Barquilha CN; Santos NJ; Monção CCD; Barbosa IC; Lima FO; Justulin LA; Pértega-Gomes N; Felisbino SL
Oxid Med Cell Longev; 2020; 2020():2148562. PubMed ID: 32411320
[TBL] [Abstract][Full Text] [Related]
28. Lysophosphatidic acid decreased macrophage foam cell migration correlated with downregulation of fucosyltransferase 8 via HNF1α.
Chen L; Zhang J; Yang X; Liu Y; Deng X; Yu C
Atherosclerosis; 2019 Nov; 290():19-30. PubMed ID: 31557675
[TBL] [Abstract][Full Text] [Related]
29. Fucosyltransferase 8 as a functional regulator of nonsmall cell lung cancer.
Chen CY; Jan YH; Juan YH; Yang CJ; Huang MS; Yu CJ; Yang PC; Hsiao M; Hsu TL; Wong CH
Proc Natl Acad Sci U S A; 2013 Jan; 110(2):630-5. PubMed ID: 23267084
[TBL] [Abstract][Full Text] [Related]
30. Interleukin-6/signal transducer and activator of transcription 3 promotes prostate cancer resistance to androgen deprivation therapy via regulating pituitary tumor transforming gene 1 expression.
Huang S; Liu Q; Liao Q; Wu Q; Sun B; Yang Z; Hu X; Tan M; Li L
Cancer Sci; 2018 Mar; 109(3):678-687. PubMed ID: 29288516
[TBL] [Abstract][Full Text] [Related]
31. A lectin-based glycomic approach identifies FUT8 as a driver of radioresistance in oesophageal squamous cell carcinoma.
Shen L; Xia M; Deng X; Ke Q; Zhang C; Peng F; Dong X; Luo Z
Cell Oncol (Dordr); 2020 Aug; 43(4):695-707. PubMed ID: 32474852
[TBL] [Abstract][Full Text] [Related]
32. Glutaminolysis is a metabolic route essential for survival and growth of prostate cancer cells and a target of 5α-dihydrotestosterone regulation.
Cardoso HJ; Figueira MI; Vaz CV; Carvalho TMA; Brás LA; Madureira PA; Oliveira PJ; Sardão VA; Socorro S
Cell Oncol (Dordr); 2021 Apr; 44(2):385-403. PubMed ID: 33464483
[TBL] [Abstract][Full Text] [Related]
33. miR-30a inhibits androgen-independent growth of prostate cancer via targeting MYBL2, FOXD1, and SOX4.
Li X; Jiao M; Hu J; Qi M; Zhang J; Zhao M; Liu H; Xiong X; Dong X; Han B
Prostate; 2020 Jun; 80(9):674-686. PubMed ID: 32294305
[TBL] [Abstract][Full Text] [Related]
34. Calcium signaling in prostate cancer cells of increasing malignancy.
Marchetti C
Biomol Concepts; 2022 Mar; 13(1):156-163. PubMed ID: 35334188
[TBL] [Abstract][Full Text] [Related]
35. Identification of PRL1 as a novel diagnostic and therapeutic target for castration-resistant prostate cancer by the Escherichia coli ampicillin secretion trap (CAST) method.
Shinmei S; Sentani K; Hayashi T; Sakamoto N; Goto K; Oo HZ; Naito Y; Teishima J; Matsubara A; Oue N; Kuniyasu H; Yasui W
Urol Oncol; 2014 Aug; 32(6):769-78. PubMed ID: 24968948
[TBL] [Abstract][Full Text] [Related]
36. Role of FUT8 expression in clinicopathology and patient survival for various malignant tumor types: a systematic review and meta-analysis.
Ma M; Han G; Wang Y; Zhao Z; Guan F; Li X
Aging (Albany NY); 2020 Dec; 13(2):2212-2230. PubMed ID: 33323540
[TBL] [Abstract][Full Text] [Related]
37. Caveolin-1 upregulates Fut8 expression by activating the Wnt/β-catenin pathway to enhance HCC cell proliferative and invasive ability.
Zhang C; Wu Q; Huang H; Chen X; Huang T; Li W; Zhang J; Liu Y
Cell Biol Int; 2020 Nov; 44(11):2202-2212. PubMed ID: 32710651
[TBL] [Abstract][Full Text] [Related]
38. Androgens induce a distinct response of epithelial-mesenchymal transition factors in human prostate cancer cells.
Colditz J; Rupf B; Maiwald C; Baniahmad A
Mol Cell Biochem; 2016 Oct; 421(1-2):139-47. PubMed ID: 27562825
[TBL] [Abstract][Full Text] [Related]
39. Circular RNA cir-ITCH Is a Potential Therapeutic Target for the Treatment of Castration-Resistant Prostate Cancer.
Li S; Yu C; Zhang Y; Liu J; Jia Y; Sun F; Zhang P; Li J; Guo L; Xiao H; Gao F; Deng X; Cai Z; Cai J
Biomed Res Int; 2020; 2020():7586521. PubMed ID: 32904490
[TBL] [Abstract][Full Text] [Related]
40. Characterizing the molecular features of ERG-positive tumors in primary and castration resistant prostate cancer.
Roudier MP; Winters BR; Coleman I; Lam HM; Zhang X; Coleman R; Chéry L; True LD; Higano CS; Montgomery B; Lange PH; Snyder LA; Srivastava S; Corey E; Vessella RL; Nelson PS; Üren A; Morrissey C
Prostate; 2016 Jun; 76(9):810-22. PubMed ID: 26990456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
